Farther Finance Advisors, LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in TMO

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$4,868,113

-$660,998 QoQ

Shares Held

9,904

+3.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $17,580,572 across 34 Diagnostics & Research names. TMO ranks #1 (27.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc. This page	9,904	$4,868,113
2	DHR	Danaher Corp /De/	18,582	$3,523,147
3	IQV	Iqvia Holdings Inc.	12,310	$2,099,347
4	IDXX	Idexx Laboratories Inc /De	2,593	$1,456,980
5	MEDP	Medpace Holdings, Inc.	2,083	$1,000,235
6	LH	Labcorp Holdings Inc.	3,417	$911,689
7	WAT	Waters Corp /De/	1,973	$587,559
8	A	Agilent Technologies, Inc.	5,090	$580,158

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,868,113	9,904	+3.8%	Shares	Sole	2026-04-07
2025-12-31	$5,529,111	9,542	+24.1%	Shares	Sole	2026-01-23
2025-09-30	$3,728,833	7,688	+17.5%	Shares	Sole	2025-10-14
2025-06-30	$2,653,330	6,544	+29.6%	Shares	Sole	2025-07-11
2025-03-31	$2,511,884	5,048	+27.9%	Shares	Sole	2025-04-14
2024-12-31	$2,053,868	3,948	+3.2%	Shares	Sole	2025-02-10
2024-09-30	$2,365,411	3,824	+16.4%	Shares	Sole	2024-10-29
2024-06-30	$1,816,605	3,285	+47.0%	Shares	Sole	2024-07-31
2024-03-31	$1,298,423	2,234	+29.5%	Shares	Sole	2024-05-14
2023-12-31	$915,612	1,725	+44.4%	Shares	Sole	2024-02-15
2023-09-30	$604,873	1,195	+3.4%	Shares	Sole	2023-11-14
2023-06-30	$603,143	1,156	+28.2%	Shares	Sole	2024-05-14
2023-03-31	$519,885	902	+234.1%	Shares	Sole	2024-05-14
2022-12-31	$148,686	270	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.